Continuous Processing – To Engage or Not to Engage?
Posted on October 26, 2020
Rob Bowen, Process Architect and Director
Facilities Integration
Continuous processing, as to an extent with closed processing, is a difficult area of engagement for the pharmaceutical industry. The article considers why this is the case and whether there are fundamental issues that prevent taking continuous processes on board. With concerns about drug shortages ...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy















